Recipient Immune Modulation with Atorvastatin for Acute Graft-versus-Host Disease Prophylaxis after Allogeneic Transplantation-Reference-Cited by-同舟云学术

Recipient Immune Modulation with Atorvastatin for Acute Graft-versus-Host Disease Prophylaxis after Allogeneic Transplantation

Published:2017-08 Issue:8 Volume:23 Page:1295-1302
ISSN:1083-8791
Container-title:Biology of Blood and Marrow Transplantation
language:en
Short-container-title:Biology of Blood and Marrow Transplantation

Author:

Kanate Abraham S.,Hari Parameswaran N.,Pasquini Marcelo C.,Visotcky Alexis,Ahn Kwang W.,Boyd Jennifer,Guru Murthy Guru Subramanian,Rizzo J. Douglas,Saber Wael,Drobyski William,Michaelis Laura,Atallah Ehab,Carlson Karen S.,D'Souza Anita,Fenske Timothy S.,Cumpston Aaron,Bunner Pamela,Craig Michael,Horowitz Mary M.,Hamadani Mehdi^ORCID

Funder

American Cancer Society

Publisher

Elsevier BV

Subject

Transplantation,Hematology

Reference44 articles.

1. Graft-versus-host disease;Ferrara;Lancet,2009

2. Acute graft-versus-host disease: from the bench to the bedside;Socié;Blood,2009

3. Graft-versus-host disease;Ferrara;N Engl J Med,1991

4. Relation of an interleukin-10 promoter polymorphism to graft-versus-host disease and survival after hematopoietic-cell transplantation;Lin;N Engl J Med,2003

5. Genetic variation in the IL-10 pathway modulates severity of acute graft-versus-host disease following hematopoietic cell transplantation: synergism between IL-10 genotype of patient and IL-10 receptor beta genotype of donor;Lin;Blood,2005

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. New target-HMGCR inhibitors for the treatment of primary sclerosing cholangitis: a drug Mendelian randomization study;2024-04-25

2. New target-HMGCR inhibitors for the treatment of primary sclerosing cholangitis: A drug Mendelian randomization study;Open Medicine;2024-01-01

3. Impact of Donor Statin Treatment on Graft-versus-Host Disease after Allogeneic Hematopoietic Cell Transplantation;Transplantation and Cellular Therapy;2023-11

4. Putting function back in dysfunction: Endothelial diseases and current therapies in hematopoietic stem cell transplantation and cellular therapies;Blood Reviews;2022-01

5. Endothelial cell dysfunction: a key determinant for the outcome of allogeneic stem cell transplantation;Bone Marrow Transplantation;2021-07-12